Novel oral OAB agent now available to pharmacies

Article

Astellas Pharma US, Inc. has announced that mirabegron (Myrbetriq), indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency, is now available through U.S. pharmacies.

Related Videos
Roger R. Dmochowski, MD, MMHC, FACS, answers a question during a Zoom video interview
Smita De, MD, PhD, answers a question during a Zoom video interview
Related Content
© 2023 MJH Life Sciences

All rights reserved.